Impacts of florfenicol on the microbiota landscape and resistome as revealed by metagenomic analysis
Abstract Background Drug-resistant fish pathogens can cause significant economic loss to fish farmers. Since 2012, florfenicol has become an approved drug for treating both septicemia and columnaris diseases in freshwater fish. Due to the limited drug options available for aquaculture, the impact of...
|Main Authors:||, , ,|